Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

SHA/600420 stock hub

SHA/600420 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SHA/600420is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

12.9B

Shanghai Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

SHA/600420

In the news

Latest news · SHA/600420

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 17.1P50 24.2P75 37.8

Trailing P/E17.9

P25 23.5P50 41.3P75 83.2

ROE5.7

P25 -0.9P50 4.1P75 8.8

ROIC7.1

P25 -0.5P50 5P75 11.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SHA/600420 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

238

Groups with data

Currency

CNY

Showing 238 of 238 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	CN
Employees	9,697
Employees Change	-1,775%
Employees Change Percent	-15.47
Enterprise value	CNY 11.3B
Exchange	Shanghai Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	CNE000001JG2
Last refreshed	2026-05-10
Market cap	CNY 12.9B
Price	CNY 9.61
Price currency	CNY
Rev Per Employee	909,622.03x
Sector	Healthcare
Sic	2834
Symbol	sha/600420
Website	https://www.shyndec.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	5.58%
EV Earnings	15.74x
EV/EBIT	12.94x
EV/EBITDA	7.22x
EV/FCF	14.84x
EV/Sales	1.28x
FCF yield	5.91%
P/B ratio	0.8x
P/E ratio	17.94x
P/S ratio	1.46x
PE Ratio10 Y	18.08x
PE Ratio3 Y	15.99x
PE Ratio5 Y	17.52x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	9.91%
EBITDA Margin	17.63%
FCF margin	8.64%
Gross margin	29.27%
Gross Profit	CNY 2.6B
Gross Profit Growth	-32.22%
Gross Profit Growth Q	-35.53%
Gross Profit Growth3 Y	-19.06%
Gross Profit Growth5 Y	-15.88%
Net Income	CNY 718.6M
Net Income Growth	-35.48%
Net Income Growth Q	-61.71%
Net Income Growth Years	0%
Net Income Growth3 Y	-0.5%
Net Income Growth5 Y	-0.43%
Pretax Margin	12.07%
Profit Margin	8.15%
Profit Per Employee	CNY 74,104
Profitable Years	25
ROA	2.82
Roa5y	3.59
ROCE	5.37
ROE	5.73
Roe5y	7.89
ROIC	7.07
Roic5y	10.12

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-2.62%
Cagr15y	2.62%
Cagr1y	-4.32%
Cagr20y	7.25%
Cagr3y	-8.55%
Cagr5y	-0.08%
Div CAGR10	28.21%
Div CAGR3	14.47%
Div CAGR5	24.57%
EPS Growth	-35.48
EPS Growth Q	-61.71
EPS Growth Years	0
EPS Growth3 Y	-4.11
EPS Growth5 Y	-2.93
FCF Growth	-53.31%
FCF Growth3 Y	-31.79%
FCF Growth5 Y	-12.31%
OCF Growth	-44.31%
OCF Growth10 Y	-6%
OCF Growth3 Y	-27.55%
OCF Growth5 Y	-12.45%
Revenue Growth	-15.36x
Revenue Growth Q	-20.81x
Revenue Growth Years	0x
Revenue Growth3 Y	-12.42x
Revenue Growth5 Y	-7.72x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CNY 0.45
Assets	CNY 19.5B
Cash	CNY 3.7B
Current Assets	CNY 11.4B
Current Liabilities	CNY 3.2B
Debt	CNY 28.9M
Debt EBITDA	CNY 0.02
Debt Equity	CNY 0
Debt FCF	CNY 0.04
Equity	CNY 16B
Interest Coverage	248.6
Liabilities	CNY 3.4B
Long Term Assets	CNY 8B
Long Term Liabilities	CNY 246.1M
Net Cash	CNY 3.7B
Net Cash By Market Cap	CNY 28.67
Net Cash Growth	-26.09%
Net Debt EBITDA	CNY -2.38
Net Debt Equity	CNY -0.23
Net Debt FCF	CNY -4.85
Tangible Book Value	CNY 13B
Tangible Book Value Per Share	CNY 9.7
WACC	5.06

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.59
Inventory Turnover	3.17
Net Working Capital	CNY 4.5B
Quick ratio	1.76
Working Capital	CNY 8.2B
Working Capital Turnover	CNY 1.11

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0%
Dividend Growth	50%
Dividend Growth Years	2%
Dividend per share	CNY 0.3
Dividend Years	11
Dividend Yield	3.12%
Last Dividend	CNY 0.1
Payout Ratio	55.18%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-23.34%
1Y total return	-4.32%
200-day SMA	10.66
3Y total return	-23.52%
50-day SMA	10.3
50-day SMA vs 200-day SMA	50under200
5Y total return	-0.39%
All Time High	30.33
All Time High Change	-68.31%
All Time High Date	2015-06-04
All Time Low	1.07
All Time Low Change	795.62%
All Time Low Date	2004-08-30
ATR	0.17
Beta	0.15
Beta1y	-0.03
Beta2y	0.43
Ch YTD	-4.85
High	9.68
High52	11.8
High52 Date	2025-07-31
High52ch	-18.56%
Low	9.58
Low52	9.45
Low52 Date	2026-04-30
Low52ch	1.69%
Ma50ch	-6.7%
Price vs 200-day SMA	-9.81%
RSI	34.45
RSI Monthly	42.01
RSI Weekly	32.33
Sharpe ratio	-0.32x
Sortino ratio	-0.1
Total Return	3.12%
Tr YTD	-4.85
Tr15y	47.48%
Tr1m	-8.56%
Tr1w	-0.21%
Tr3m	-10.35%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CNY 874.5M
Operating Income Growth	-42.99
Operating Income Growth Q	-49.03
Operating Income Growth3 Y	-3.67
Operating Income Growth5 Y	-6.47
Operating margin	9.91

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	559,917,981%
Net Borrowing	-60,299,783
Shares Insiders	0.01%
Shares Institutions	4.27%
Shares Out	1,341,172,692
Shares Qo Q	-0.01%
Shares Yo Y	0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CNY 762.4M
Average Volume	10,376,835.6x
Bv Per Share	10.38
CAPEX	CNY -267.6M
Ch10y	-31.43
Ch15y	30.48
Ch1m	-8.56
Ch1w	-0.21
Ch1y	-6.88
Ch20y	245.2
Ch3m	-10.35
Ch3y	-27.64
Ch5y	-7.68
Ch6m	-8.39
Change	-0.31%
Change From Open	-0.31
Close	9.64
Days Gap	0
Depreciation Amortization	680,156,275
Dollar Volume	77,223,077
Earnings Date	2026-04-30
EBIT	CNY 874.5M
EBITDA	CNY 1.6B
EPS	CNY 0.54
F Score	5
FCF	CNY 762.4M
FCF EV Yield	6.74x
FCF Per Share	CNY 0.57
Financing CF	-533,525,016
Fiscal Year End	December
Founded	1,996
Goodwill	160,151,939
Graham Number	11.18526
Graham Upside	16.39
Income Tax	CNY 154.1M
Investing CF	-2,004,860,424
Is Primary Listing	1
Last Earnings Date	2026-04-30
Last Report Date	2026-03-31
Last Split Date	2017-05-25
Last Split Type	Forward
Lynch Fair Value	CNY 2.68
Lynch Upside	-72.12
Ma150	10.45
Ma150ch	-8.06%
Ma20	9.83
Ma20ch	-2.26%
Net CF	-1,511,404,314
Open	9.64
P FCF Ratio	16.91
P OCF Ratio	12.51
Payment Date	2025-09-16
Position In Range	30
Ppne	5,243,187,562
Price Date	2026-05-08
Price EBITDA	CNY 8.29
Ptbv Ratio	0.99
Relative Volume	0.76x
Revenue	8,820,604,869x
Tax By Revenue	1.75x
Tax Rate	14.47%
Tr20y	305.38%
Tr6m	-8.39%
Volume	8,035,700

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

SHA/600420 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+3.1%

$0.30 annual per share

Payout ratio

+55.2%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+24.6%

2 consecutive years of growth

Total shareholder yield

+3.1%

Dividend yield + buyback yield combined

Performance

SHA/600420 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SHA/600420?

Insider, institutional, and short-interest positioning.

Institutional ownership

+4.3%

Share of float held by funds and institutions

Insider ownership

+0.0%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.0%

Negative means the company is buying back shares.

Technical

SHA/600420 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

34.5

Neutral momentum band

Price vs 200-day MA

-9.8%

50/200-day relationship not available

Beta (5Y)

0.15

Less volatile than the market

Sharpe ratio

-0.32

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SHA/600420

Hub-level FAQ points readers to the deeper analysis pages.

What is the current sha/600420 stock rating?

sha/600420 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full sha/600420 analysis?

The full report lives at /stocks/sha/600420/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for sha/600420?

The latest report frames sha/600420 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the sha/600420 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.